PARP Inhibitors and Heart Failure—Translational Medicine Caught in the Act

    loading  Checking for direct PDF access through Ovid


With the introduction of this new section, “Spotlight on Heart Failure Translational Research,” Congestive Heart Failure recognizes the importance of the cutting-edge research that frequently translates to clinical practice in a rapid timeframe. It is the intent of the Co-Editors in Chief to provide the readership with a window on the future of heart failure therapeutics through the introduction of this section. Dr. George W. Booz, Section Editor for this pivotal area, cordially invites the submission of translational research in all aspects of heart failure for review and potential publication within this section.—John E. Strobeck, MD, PhD and Marc A. Silver, MD, Co-Editors in Chief

Related Topics

    loading  Loading Related Articles